ライフサイエンスコーパス: convalescence

1 n (2.3%) or in early (26.6%) or late (58.6%) convalescence.

2 the late stages of acute disease or in early convalescence.

3 PCR were performed at enrollment and during convalescence.

4 und to have severe unilateral uveitis during convalescence.

5 han those based on ecological competition by convalescence.

6 ral blood B cells during acute infection and convalescence.

7 on methods are best utilized during presumed convalescence.

8 ed when IL-10 levels returned to baseline by convalescence.

9 t showed significant morbidity and prolonged convalescence.

10 roved intraoperative morbidity and decreased convalescence.

11 eatment is effective but entails significant convalescence.

12 ed up to 8% during acute infection and early convalescence.

13 concentrations returning to baseline during convalescence.

14 ins associated with subclinical infection or convalescence.

15 F excretion, which returned to normal during convalescence.

16 the systemic angiogenic process during early convalescence.

17 od loss, a shorter hospital stay, and faster convalescence.

18 des briefer, less intense, and more complete convalescence.

19 sion; bactericidal activity developed during convalescence.

20 d that IFA is useful for diagnosis of HGE in convalescence.

21 and if secondary transmission occurs during convalescence.

22 amples obtained during the acute illness and convalescence.

23 tients who provided multiple samples through convalescence.

24 virus (EBV) during both acute infection and convalescence.

25 le, and similar patterns of clearance during convalescence.

26 te disease (0.29 +/- 0.02 g/L) compared with convalescence (0.40 +/- 0.04 g/L), although not statisti

27 acute disease (36.9% +/- 2.5%) compared with convalescence (18.8% +/- 1.5%; p =.0003).

28 (43.5+/-14.1 vs. 45.7+/-25.3 hours, P =0.1; convalescence 23.5+/-5.3 vs. 20.2+/-4.1 days, P =0.5).

29 sonance imaging acutely (24-72 hours) and at convalescence (3 months).

30 By convalescence, 65% of patients had positive IgM or IgG a

31 acute patients (53.3 +/- 4.4%) compared with convalescence (67.8 +/- 3.2%; p =.015).

32 l injury have a large negative effect on the convalescence after abdominal surgery.

33 ions that include uveitis can develop during convalescence, although the incidence and pathogenesis o

34 During convalescence, an increasing proportion of pp65-specific

35 -adjusted SR cutoffs of 0.6 mumol/L for late convalescence and 0.5 mumol/L for early convalescence, t

36 hospitalization, postoperative pain, time to convalescence and activity, while providing an optimal c

37 We monitored primary infection during convalescence and during the establishment of persistent

38 ical processes such as a temporary period of convalescence and pathogen-induced mortality have led to

39 postoperative complications lead to shorter convalescence and possibly improved 30-day survival.

40 nyan children with severe malaria and during convalescence and related these parameters to the adhesi

41 mmediately after blood-stage infection or at convalescence, and for most subsets was directly associa

42 P lt 0.001) higher in the incubation, early convalescence, and late convalescence subgroups, respect

43 condary endpoints were morbidity, mortality, convalescence, and pathology.

44 ine month period encompassing acute disease, convalescence, and recovery.

45 of acute pneumonia, to estimate mortality at convalescence, and to analyse mortality risk-factors.

46 Clinical sequelae during early EVD convalescence are common and sometimes sight threatening

47 s a result of prolonged hospitalizations and convalescence associated with antibiotic treatment failu

48 e pain, cosmetic concerns, and the prolonged convalescence associated with the donor operation.

49 During convalescence, at the conclusion of antibiotic therapy,

50 APP), incubation (elevated CRP only), early convalescence (both APP and CRP elevated), and late conv

51 Because of shortened hospitalization and convalescence, CAS challenges CEA as the preferred treat

52 gly popular owing to decreased morbidity and convalescence compared with open procedures.

53 L, and transfusion rates as well as improved convalescence compared with open-radical cystectomy.

54 h a briefer, less intense, and more complete convalescence compared with the open surgical approach.

55 obtained from three of these patients during convalescence contained antibodies that reacted with E.

56 om acute infectious mononucleosis (AIM) into convalescence (CONV).

57 osis [AIM]) and again 6 months later (during convalescence [CONV]).

58 ck (day0) and returned to normal values upon convalescence (day28).

59 ic surgeries offer added benefits of earlier convalescence, decreased blood loss, as well as decrease

60 scence (both APP and CRP elevated), and late convalescence (elevated AGP only).

61 supply while minimizing pain and duration of convalescence for donors.

62 ewer wound-related complications, and faster convalescence for patients who underwent laparoscopic ga

63 ring the acute phase of infection and during convalescence for WHcAg and WHxAg expression by immunohi

64 As a result, visual outcomes and patient convalescence have improved significantly.

65 ude reduced postoperative pain and shortened convalescence; however, there are few data with respect

66 of plasma endothelial markers acutely and in convalescence in Malawian children with uncomplicated or

67 IgG levels rose significantly during convalescence in patients with bacteremic pneumonia, rea

68 he potential decrease in hospitalization and convalescence may also prove to be financially advantage

69 =.001) and decreased 1.5-fold (P=.01) during convalescence (median, 15 days).

70 IC) and euthanized acutely (n = 43) or after convalescence (n = 22).

71 of acute EVD with the following outcomes in convalescence: new ocular symptoms, uveitis, auditory sy

72 re arising, and may enable us to improve the convalescence of larger numbers of our patients.

73 During convalescence, only IgG (and no IgA) RSV-specific memory

74 s, serum neutralizing antibody titers during convalescence, or duration of mechanical ventilation, in

75 present for months, or indefinitely, in the convalescence phase of critical illness.

76 the onset of severe clinical symptoms to the convalescence phase.

77 Convalescence-phase sera from humans were similarly inef

78 e the serum neutralizing antibody responses, convalescence-phase serum samples from people previously

79 y, there was a strong, distinct signature of convalescence present at day 9 after infection that rema

80 neutralizing antibodies that develop during convalescence prevent reinfection in animal models.

81 d loss, length of hospital stay, pain score, convalescence, quality of life, and costs.

82 g the acute phase and 72, 44, and 32% during convalescence, respectively.

83 eral blood that changed during treatment and convalescence, returning in the majority of cases to the

84 isode and compared them with findings from a convalescence sample.

85 he incubation, early convalescence, and late convalescence subgroups, respectively, with correspondin

86 undergo coronary angioplasty have a shorter convalescence than those who undergo coronary bypass sur

87 During convalescence the phenotype switches to small and large

88 late convalescence and 0.5 mumol/L for early convalescence, the adjusted prevalence of SR deficiency

89 ecurrence, as well as postoperative pain and convalescence, the treatment of inguinal hernias underwe

90 n important role in decreasing postoperative convalescence through maintaining preoperative mydriasis

91 -donor nephrectomy, as it results in a short convalescence time and increased quality of life.

92 oncologic control, low morbidity and shorter convalescence time.

93 The titers both at presentation and after convalescence were not associated with the HRV genotype

94 f disease and 100% of the dogs tested during convalescence were seropositive for E. equi antigens.

95 Donor length of stay and convalescence were similar in both groups (43.5+/-14.1 v

96 n important role in decreasing postoperative convalescence with fewer side effects.

97 cumulate to strikingly high frequencies into convalescence without continued proliferation.

98 his approach in regards to complications and convalescence without evidence of compromise to early an